NCT03318614View on ClinicalTrials.gov

Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Irritable Bowel SyndromeAbdominal PainSmall Intestinal Bacterial Overgrowth
Interventions
DIETARY_SUPPLEMENT

Probiotics M-63

B. infantis M63 (2.5 x 109 cfu/g per sachet) was given to Probiotics M-63 group for three months.

OTHER

Control group

No probiotic intervention was given to the control group for three months.

All Listed Sponsors
collaborator

Morinaga Milk Industry Co., LTD

INDUSTRY

lead

Universiti Sains Malaysia

OTHER

NCT03318614 - Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster | Biotech Hunter | Biotech Hunter